Results 231 to 240 of about 30,963 (261)
Some of the next articles are maybe not open access.
[Pseudophakic cystoid macular oedema].
Klinische Monatsblatter fur Augenheilkunde, 2013Pseudophakic cystoid macular oedema is still a relevant clinical disease entity although major progress in modern cataract surgery has been made within the last decades. The relevance is attributed to the large number of cases that are performed each year.
T, Bertelmann, M, Witteborn, S, Mennel
openaire +1 more source
Pseudophakic Cystoid Macular Oedema
2020Cystoid macular oedema (CMO) is a relatively common condition and is associated with various ocular conditions. CMO which develops after a cataract surgery and when its cause is presumed to be directly related to the surgery, it is referred to as pseudophakic CMO or Irvine–Gass syndrome.
openaire +1 more source
The diagnostic value of systemic immune-inflammation index in diabetic macular oedema
Australasian journal of optometry, The, 2022Bengi Ece Kurtul +2 more
exaly
Paclitaxel‐induced cystoid macular oedema
Acta Ophthalmologica, 2016Shin-Yu, Chang +3 more
openaire +2 more sources
Tomographic assessment of therapeutic response to uveitic macular oedema
Clinical and Experimental Ophthalmology, 2007Sobha Sivaprasad, Susan Lightman
exaly
[Treatment of diabetic macular oedema].
Vnitrni lekarstvi, 2013Diabetic macular oedema (DMO) is currently the main complication associated with diabetes. The percentage of patients with DMO grows alongside the increasing number of diabetes occurrences. The DMO treatment has seen major developments in the past few years.
openaire +1 more source